BIOCON2023-04-012023-06-30 BIOCON2023-04-012023-06-30in-bse-fin:OneOperatingExpenses01Member BIOCON2023-04-012023-06-30in-bse-fin:OneOperatingExpenses02Member BIOCON2023-06-30 BIOCON2023-04-012023-06-30in-bse-fin:OneItemsThatWillNotBeReclassifiedToProfitAndLoss01Member BIOCON2023-04-012023-06-30in-bse-fin:OneItemsThatWillBeReclassifiedToProfitAndLoss01Member iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares 532523 BIOCON NOTLISTED Biocon Limited Equity 2023-04-01 2024-03-31 2023-08-10 2023-07-21 INR Millions First quarter 17:45:00 19:25:00 2023-08-10 2023-08-10 Not applicable Single segment Pharmaceutical 2023-04-01 2023-06-30 Unaudited Standalone 5132000000.00 360000000.00 5492000000.00 2597000000.00 0.00 -392000000.00 1054000000.00 483000000.00 298000000.00 1153000000.00 5193000000.00 299000000.00 197000000.00 496000000.00 39000000.00 -9000000.00 30000000.00 0.00 466000000.00 0.00 0.00 0.00 0.00 466000000.00 37000000.00 503000000.00 0.00 0.00 6003000000.00 5 0.39 0.39 0.00 0.00 0.39 0.39 Notes: 1.The unaudited standalone and consolidated financial results for the quarter ended June 30, 2023 in respect of Biocon Limited (‘the Company’) have been reviewed by the Audit Committee and approved by the Board of Directors of the Company at their respective meetings held on August 10, 2023. The above results have been subjected to limited review by the statutory auditors of the Company. The reports of the statutory auditors are unqualified. 2.These financial results have been prepared in accordance with Indian Accounting Standards (‘Ind AS’) prescribed under Section 133 of the Companies Act, 2013 and other accounting principles generally accepted in India and in terms of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Due to size constraints, we are unable to provide full Notes in XBRL. Please refer Outcome of Board Meeying dated August 10, 2023 for full notes to the financial results for quarter ended 30.06.2023. Less: Recovery of cost from co-development partners (net) -3000000.00 Other 1156000000.00 Items that will not be reclassified to profit or loss -19000000.00 -19000000.00 -5000000.00 Items that will be reclassified to profit or loss 68000000.00 68000000.00 17000000.00